Your browser doesn't support javascript.
loading
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization.
Kim, E Seul; Lee, Min Sang; Jeong, Hayoung; Lim, Su Yeon; Kim, Doha; Kim, Dahwun; Jung, Jaeback; Lyu, Siyan; Cho, Hee Joo; Kim, Dong Min; Suh, Wonhee; Jeong, Ji Hoon.
Afiliación
  • Kim ES; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Lee MS; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Jeong H; Department of Global Innovative Drug, Graduate School of Chung-Ang University, Seoul 06974, Korea.
  • Lim SY; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
  • Kim D; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Kim D; Department of Global Innovative Drug, Graduate School of Chung-Ang University, Seoul 06974, Korea.
  • Jung J; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
  • Lyu S; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Cho HJ; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Kim DM; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Suh W; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
  • Jeong JH; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Pharmaceutics ; 13(10)2021 Sep 24.
Article en En | MEDLINE | ID: mdl-34683841
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article